Juha S. Perkiomaki

Juha S. Perkiomaki

Auto-generated profile, based on publicly available information

Juha S. Perkiomaki

Research Unit of Biomedicine and Internal Medicine, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2007 in Diabetologia
Verified
Journal Article
Closed access
PDF file
MKM. L. Koivikko
M. L. Koivikko
MKM. Karsikas
M. Karsikas
PSP. I. Salmela
P. I. Salmela
JTJ. S. Tapanainen
J. S. Tapanainen
ARA. Ruokonen
A. Ruokonen
JPJ. S. Perkiömäki
J. S. Perkiömäki

29 September 2022 in European Heart Journal
Verified
Journal Article
Open access
PDF file
LHLauri Holmström
Lauri Holmström
SJSamuli Juntunen
Samuli Juntunen
JVJuha Vähätalo
Juha Vähätalo
LPLasse Pakanen
Lasse Pakanen
KKKari Kaikkonen
Kari Kaikkonen
Juhani JunttilaJuhani Junttila
Juhani Junttila
Aims: At least 50% of deaths due to coronary artery disease (CAD) are sudden cardiac deaths (SCDs), but the role of acute plaque complications on the incidence of sudden death in CAD is somewhat unclear. The present study aimed to investigate plaque histology and concomitant myocardial disease in sudden coronary death.Methods and results: The study population is derived from the Fingesture study, which has collected data from 5869 consecutive autopsy-verified SCD victims in Northern Finland (population ≈600 000) between 1998 and 2017. In this substudy, histological examination of culprit lesions was performed in 600 SCD victims whose death was due to CAD. Determination of the cause of death was based on the combination of medical records, police reports, and autopsy data. Plaque histology was classified as either (i) plaque rupture or erosion, (ii) intraplaque haemorrhage, or (iii) stable plaque. The mean age of the study subjects was 64.9 ± 11.2 years, and 82% were male. Twenty-four per cent had plaque rupture or plaque erosion, 24% had an intraplaque haemorrhage, and 52% had a stable plaque. Myocardial hypertrophy was present in 78% and myocardial fibrosis in 93% of victims. The presence of myocardial hypertrophy or fibrosis was not associated with specific plaque histology.Conclusion: Less than half of sudden deaths due to CAD had evidence of acute plaque complication, an observation which is contrary to historical perceptions. The prevalence of concomitant myocardial disease was high and independent of associated plaque morphology.

1 May 2021 in The American Journal of Cardiology
Verified
Journal Article
Open access
JVJuha Vähätalo
Juha Vähätalo
LHLauri Holmström
Lauri Holmström
LPLasse Pakanen
Lasse Pakanen
KKKari Kaikkonen
Kari Kaikkonen
JPJuha Perkiömäki
Juha Perkiömäki
Juhani JunttilaJuhani Junttila
Juhani Junttila
Coronary artery disease (CAD) is the most common cause of sudden cardiac death (SCD). Atherosclerosis increases with age, but also many victims of SCD in young and middle-aged population have CAD at autopsy. The purpose of this study was to determine the characteristics and autopsy findings of SCD due to CAD among victims of SCD under the age of 50. Fingesture is a population-based study consisting of consecutive series of victims of autopsy verified SCD in Northern Finland between the years 1998 to 2017 (n = 5,869). Histological examinations were part of all autopsies and a toxicology investigation was performed if needed. Analyses included information accumulated from death certificates, medical records, autopsy data, standardized questionnaire to the closest family members of the victims of SCD and police reports of the conditions of the death. Overall, 10.4% of all SCDs occurred among victims under the age of 50 years (610 victims). Most common underlying cause of SCD among these younger SCD victims was CAD (43.6%). The prevalence of CAD as the cause of SCD became more common in young SCD victims after the age of 35 years. The mean age of ischemic SCD victims was 44±5 years and most were men (89.5%). Most victims (90.2%) had no clinical diagnosis of CAD, however 33.8% had an autopsy evidence of silent myocardial infarction. SCD occurred during physical activity in 24.1%. Three-vessel disease was detected in 44.4% of the study victims. Cardiac hypertrophy (58.3%) and myocardial fibrosis (82.6%) were also common. At least 1 cardiovascular risk factor was present in 64.7% of SCD victims. In conclusion, most SCDs among victims < 50 years of age are due to CAD.

1 December 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
SNSanteri Nortamo
Santeri Nortamo
OUOlavi Ukkola
Olavi Ukkola
SLSamuli Lepojärvi
Samuli Lepojärvi
TKTuomas Kenttä
Tuomas Kenttä
AKAntti Kiviniemi
Antti Kiviniemi
JPJuha Perkiömäki
Juha Perkiömäki

9 April 2014 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
JPJuha Perkiömäki
Juha Perkiömäki
OUOlavi Ukkola
Olavi Ukkola
AKAntti Kiviniemi
Antti Kiviniemi
MTMikko P Tulppo
Mikko P Tulppo
AYAntti Ylitalo
Antti Ylitalo
HHHeikki Huikuri
Heikki Huikuri

13 July 2015 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
ELE. Samuli Lepojärvi
E. Samuli Lepojärvi
OPOlli-Pekka Piira
Olli-Pekka Piira
EPEija Pääkkö
Eija Pääkkö
ELEveliina Lammentausta
Eveliina Lammentausta
JRJuha Risteli
Juha Risteli
Juhani JunttilaJuhani Junttila
Juhani Junttila
Objectives and Background. Serum biomarkers have been proposed to reflect fibrosis of several human tissues, but their specific role in the detection of myocardial fibrosis has not been well established. We studied the association between N-terminal propeptide of type I and III procollagen (PINP, PIIINP, respectively), galectin-3 (gal-3), soluble ST2 (ST2) and myocardial fibrosis measured by late gadolinium enhanced cardiac magnetic resonance imaging (LGE CMR) and their relation to left ventricular diastolic filling properties measured by tissue Doppler echocardiography (E/e´) in patients with stable coronary artery disease (CAD). Methods and Results. We determined the PINP, PIIINP, gal-3 and ST2 serum levels and performed LGE CMR and echocardiography on 63 patients with stable CAD without a history of prior myocardial infarction. Myocardial late gadolinium enhancement T1 relaxation time was defined as a specific marker of myocardial fibrosis. ST2, PINP and PIIINP did not have a significant correlation with the post-LGE T1 relaxation time tertiles (NS for all), but the lowest post-LGE T1 relaxation time tertile had significantly higher gal-3 values than the other two tertiles (p= 0,002 and 0.002) and higher E/é values (p= 0,009) compared to the highest T1 relaxation time tertile. ST2 (p= 0.025 and 0.029), gal-3 (p= 0.003 and < 0.001) and PIIINP (p= 0.001 and 0.007) levels were also significantly higher in the highest E/é tertile, compared to the other two tertiles. Conclusions. Elevated serum levels of gal-3 reflect the degree of myocardial fibrosis assessed by LGE CMR. Gal-3, ST2 and PIIINP are also elevated in patients with impaired LV diastolic function, suggesting that these biomarkers are useful surrogates of structural and functional abnormality of the myocardium.